SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
SCYNEXIS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$3.66−0.01 (-0.27%)
Close on Oct 19, 2026
- Market cap
- $43.28M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
51.7%
5M of 10M shares
Institutional holders
39
39 new, 0 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $0
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Squadron Master Fund LP | 7,608,695 | 9.60% | 13G (passive) | Mar 31, 2026 |
| Heights Capital Management, Inc. | 615,522 | 5.90% | 13G (passive) amendment | Jun 30, 2026 |
| Avidity Private Master Fund I LP | 4,516,757 | 9.90% | 13G (passive) amendment | Sep 30, 2025 |
| Michael Gregory | 4,426,565 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Avidity Master Fund LP | 4,211,870 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Great Point Partners, LLC | 4,076,068 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| CVI Investments, Inc. | 3,956,319 | 6.20% | 13G (passive) amendment | Mar 31, 2026 |
| Voting Shares Irrevocable Trust | 3,533,250 | 8.42% | 13G (passive) amendment | Dec 31, 2025 |
| Adage Capital Management, L.P. | 1,041,824 | 9.99% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SCYX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Great Point Partners LLC | 944,292 | 9.49% | $3.84M | New | 0.73% |
| Squadron Capital Management LLC | 756,884 | 7.61% | $3.08M | New | 0.96% |
| Propel Bio Management, LLC | 543,478 | 5.46% | $2.21M | New | 1.16% |
| Adage Capital Partners Gp, L.L.C. | 543,478 | 5.46% | $2.21M | New | 0.00% |
| Woodline Partners LP | 387,520 | 3.89% | $1.58M | New | 0.00% |
| Vanguard Capital Management LLC | 296,747 | 2.98% | $1.21M | New | 0.00% |
| Avidity Partners Management LP | 260,206 | 2.62% | $1.06M | New | 0.17% |
| Kingdon Capital Management, L.L.C. | 247,811 | 2.49% | $1.01M | New | 0.10% |
| Millennium Management LLC | 180,788 | 1.82% | $735.81K | New | 0.00% |
| Heights Capital Management, Inc | 150,551 | 1.51% | $612.74K | New | 0.14% |
| DAFNA Capital Management LLC | 135,868 | 1.37% | $552.98K | New | 0.11% |
| Empery Asset Management, LP | 126,451 | 1.27% | $514.66K | New | 0.60% |
| Acadian Asset Management LLC | 116,669 | 1.17% | $473 | New | 0.00% |
| Geode Capital Management, LLC | 82,093 | 0.83% | $334.17K | New | 0.00% |
| Renaissance Technologies LLC | 76,525 | 0.77% | $311.46K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 57,970 | 0.58% | $235.94K | New | 0.00% |
| ADAR1 Capital Management, LLC | 49,387 | 0.50% | $201.01K | New | 0.01% |
| BlackRock, Inc. | 41,522 | 0.42% | $169.00K | New | 0.00% |
| Velan Capital Investment Management LP | 40,000 | 0.40% | $162.80K | New | 0.10% |
| Northern Trust Corp | 22,385 | 0.22% | $91.11K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 39 | 5M | 51.7% | 39 / 0 | 0 / 0 | 5M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of SCYX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 152,542 | 1.53% | $620.85K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 128,195 | 1.29% | $521.75K | 0.00% | Jun 30, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 15,462 | 0.16% | $62.93K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 5,910 | 0.06% | $24.05K | 0.00% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 5,189 | 0.05% | $25.11K | 0.00% | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 4,831 | 0.05% | $23.38K | 0.00% | Jul 31, 2026 |
| U.S. Vector Equity Portfolio | 2,278 | 0.02% | $11.03K | 0.00% | Jul 31, 2026 |
| Victory Extended Market Index Fund | 1,099 | 0.01% | $5.32K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gonzalez David Angulo | Chief Executive Officer, Director | 1,357,126 | 13.64% | Apr 2, 2026 |
| Sanjay Subramanian | Chief Financial Officer | – | – | Sep 11, 2026 |
| ivor Macleod | Chief Financial Officer | 398,529 | 4.01% | Feb 2, 2026 |
| Scott Sukenick | Chief Legal Officer | 574,539 | 5.77% | Feb 2, 2026 |
| Steven Keith Burke | Director | 5,750 | 0.06% | Sep 22, 2026 |
| Guy Macdonald | Director | 12,625 | 0.13% | Jun 30, 2026 |
| Armando Anido | Director | 11,750 | 0.12% | Jun 30, 2026 |
| Ann Hanham | Director | 11,577 | 0.12% | Jun 30, 2026 |
| Brian Philippe Tinmouth | Director | 12,125 | 0.12% | Jun 30, 2026 |
| David C. Hastings | Director | 11,522 | 0.12% | Jun 30, 2026 |
| Steven C. Gilman | Director | 70,000 | 0.70% | Jun 30, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Steven Keith Burke Director | Sep 18, 2026 | Award | +5,750 | – | – | 5,750 |
| Brian Philippe Tinmouth Director | Jun 26, 2026 | Award | +2,875 | – | – | 12,125 |
| Ann Hanham Director | Jun 26, 2026 | Award | +2,875 | – | – | 11,577 |
| Armando Anido Director | Jun 26, 2026 | Award | +2,875 | – | – | 11,750 |
| Guy Macdonald Director | Jun 26, 2026 | Award | +2,875 | – | – | 12,625 |
| David C. Hastings Director | Jun 26, 2026 | Award | +2,875 | – | – | 11,522 |
| Gonzalez David Angulo Chief Executive Officer, Director | Apr 1, 2026 | Buy | +108,695 | – | – | 1,357,126 |
| Gonzalez David Angulo Chief Executive Officer, Director | Jan 29, 2026 | Award | +391,333 | – | – | 1,244,431 |
| Scott Sukenick Chief Legal Officer | Jan 29, 2026 | Award | +129,833 | – | – | 574,539 |
| ivor Macleod Chief Financial Officer | Jan 29, 2026 | Award | +129,833 | – | – | 398,529 |
| Gonzalez David Angulo Chief Executive Officer, Director | Oct 17, 2025 | Award | +32,500 | $0.76 | $24.70K | 853,098 |
| Brian Philippe Tinmouth Director | Jun 26, 2025 | Award | +23,000 | – | – | 74,000 |
| Armando Anido Director | Jun 26, 2025 | Award | +23,000 | – | – | 71,000 |
| Steven C. Gilman Director | Jun 26, 2025 | Award | +23,000 | – | – | 70,000 |
| Ann Hanham Director | Jun 26, 2025 | Award | +23,000 | – | – | 69,622 |
| David C. Hastings Director | Jun 26, 2025 | Award | +23,000 | – | – | 69,183 |
| Guy Macdonald Director | Jun 26, 2025 | Award | +23,000 | – | – | 78,000 |
| Gonzalez David Angulo Chief Executive Officer, Director | Apr 9, 2025 | Award | +23,000 | $0.84 | $19.32K | 816,598 |
| Gonzalez David Angulo Chief Executive Officer, Director | Mar 20, 2025 | Award | +13,800 | $1.05 | $14.49K | 793,598 |
| Gonzalez David Angulo Chief Executive Officer, Director | Mar 19, 2025 | Award | +5,000 | $1.07 | $5.35K | 779,798 |
| ivor Macleod Chief Financial Officer | Jan 23, 2025 | Award | +92,511 | – | – | 260,696 |
| Gonzalez David Angulo Chief Executive Officer, Director | Jan 23, 2025 | Award | +262,927 | – | – | 770,798 |
| Scott Sukenick Chief Legal Officer | Jan 23, 2025 | Award | +92,511 | – | – | 436,706 |
| Gonzalez David Angulo Chief Executive Officer, Director | Sep 12, 2024 | Buy | +20,000 | $1.37 | $27.40K | 507,871 |
| Brian Philippe Tinmouth Director | Jun 20, 2024 | Award | +23,000 | – | – | 51,000 |
| Armando Anido Director | Jun 20, 2024 | Award | +23,000 | – | – | 48,000 |
| Steven C. Gilman Director | Jun 20, 2024 | Award | +23,000 | – | – | 47,000 |
| Guy Macdonald Director | Jun 20, 2024 | Award | +23,000 | – | – | 55,000 |
| Ann Hanham Director | Jun 20, 2024 | Award | +23,000 | – | – | 46,622 |
| David C. Hastings Director | Jun 20, 2024 | Award | +23,000 | – | – | 46,183 |
| Scott Sukenick Chief Legal Officer | Feb 16, 2024 | Tax withholding | −15,179 | $1.63 | $24.74K | 336,195 |
| Scott Sukenick Chief Legal Officer | Jan 26, 2024 | Award | +143,675 | – | – | 351,374 |
| Gonzalez David Angulo Chief Executive Officer, Director | Jan 26, 2024 | Award | +290,590 | – | – | 479,871 |
| ivor Macleod Chief Financial Officer | Jan 26, 2024 | Award | +143,675 | – | – | 160,185 |
| Ann Hanham Director | Jun 15, 2023 | Award | +10,000 | – | – | 23,622 |
| David C. Hastings Director | Jun 15, 2023 | Award | +10,000 | – | – | 23,183 |
| Steven C. Gilman Director | Jun 15, 2023 | Award | +10,000 | – | – | 24,000 |
| Brian Philippe Tinmouth Director | Jun 15, 2023 | Award | +10,000 | – | – | 28,000 |
| Guy Macdonald Director | Jun 15, 2023 | Award | +10,000 | – | – | 32,000 |
| Armando Anido Director | Jun 15, 2023 | Award | +10,000 | – | – | 25,000 |
| Scott Sukenick Chief Legal Officer | May 15, 2023 | Award | +50,000 | – | – | 203,599 |
| Scott Sukenick General Counsel | Jan 27, 2023 | Award | +100,000 | – | – | 153,599 |
| Gonzalez David Angulo Chief Executive Officer | Jan 1, 2023 | Award | +110,000 | – | – | 185,181 |
| ivor Macleod Chief Financial Officer | Oct 24, 2022 | Award | +15,000 | – | – | 15,000 |
| David C. Hastings Director | Jun 17, 2022 | Award | +10,000 | – | – | 13,183 |
| Guy Macdonald Director | Jun 17, 2022 | Award | +10,000 | – | – | 22,000 |
| Armando Anido Director | Jun 17, 2022 | Award | +10,000 | – | – | 15,000 |
| Brian Philippe Tinmouth Director | Jun 17, 2022 | Award | +10,000 | – | – | 18,000 |
| Steven C. Gilman Director | Jun 17, 2022 | Award | +10,000 | – | – | 14,000 |
| Ann Hanham Director | Jun 17, 2022 | Award | +10,000 | – | – | 13,622 |
| Marco Taglietti Chief Executive Officer, Director | Apr 26, 2022 | Buy | +75,000 | $3.00 | $225.00K | 272,068 |
| Scott Sukenick General Counsel | Apr 26, 2022 | Buy | +3,500 | $3.00 | $10.50K | 53,499 |
| Gonzalez David Angulo Chief Medical Officer | Feb 4, 2022 | Award | +51,100 | – | – | 74,981 |
| Scott Sukenick General Counsel | Feb 4, 2022 | Award | +40,700 | – | – | 49,899 |
| Christine Coyne Chief Commercial Officer | Feb 4, 2022 | Award | +43,200 | – | – | 58,200 |
| Marco Taglietti Chief Executive Officer, Director | Feb 4, 2022 | Award | +87,200 | – | – | 196,968 |
| Christine Coyne Chief Commercial Officer | May 10, 2021 | Award | +15,000 | – | – | 15,000 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jan 22, 2021 | Sale | −285,151 | $8.16 | $2.33M | 1,833,849 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jan 22, 2021 | Sale | −33,849 | $8.95 | $302.95K | 1,800,000 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jan 21, 2021 | Sale | −95,000 | $7.38 | $701.10K | 2,120,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Dec 18, 2024 | 9,418 | $11.58K | Dec 18, 2024 | Secondary Offering - Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Dec 18, 2024 | 332,668 | $409.18K | Dec 18, 2024 | Secondary Offering - Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Dec 18, 2024 | 257,914 | $317.23K | Dec 18, 2024 | Secondary Offering - Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Dec 11, 2024 | 388,113 | $477.38K | Dec 11, 2024 | Secondary Offering-Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Dec 11, 2024 | 10,988 | $13.52K | Dec 11, 2024 | Secondary Offering-Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity FUnds 10% Stockholder | Dec 11, 2024 | 300,899 | $370.11K | Dec 11, 2024 | Secondary Offering - Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Aug 27, 2024 | 9,700 | $17.17K | Aug 22, 2024 | Secondary Offering /Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Aug 27, 2024 | 272,000 | $481.44K | Aug 22, 2024 | Secondary Offering /Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Aug 27, 2024 | 338,000 | $598.26K | Aug 22, 2024 | Secondary Offering /Open Market |
| Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Aug 22, 2024 | 338,000 | $598.26K | Aug 22, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Aug 22, 2024 | 272,000 | $481.44K | Aug 22, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stockholder | Aug 22, 2024 | 9,700 | $17.17K | Aug 22, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Feb 9, 2024 | 477,101 | $1.02M | Feb 9, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds 10% Stockholder | Feb 5, 2024 | 590,000 | $1.26M | Feb 5, 2024 | Secondary Offering / Open Market |
| Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series 10% Stock | Sep 22, 2023 | 9,214 | $31.54K | Sep 21, 2023 | Secondary Offering / Open Market |